Skyhawk Therapeutics Announces the Expansion of its Global Pivotal trial into the United States, Canada, and the United Kingdom
Prilenia and Ferrer Announce Initiation of the Confirmatory PRECISE-HD Study of Pridopidine in Huntington’s Disease
Comments